Failed IVF in IndiaThe Complete Patient Guide — What Went Wrong, What to Investigate, How to Move Forward
Why IVF Fails | Chromosomal Abnormality | ERA | SDF | PGT-A | Protocol Changes | Donor Eggs | Emotional Support | 50 Questions Answered
⭐ Key Facts at a Glance — Failed IVF in India
Complete review of all previous records. Out-of-city patients: most monitoring can be done locally.
The call comes, or the test stick shows one line, or the beta-hCG number is zero — and in that moment, the weeks of injections, the early morning scans, the surgical retrieval, the nail-biting wait through embryo development, the transfer, the two-week wait of agonising hope — all of it collapses into a single devastating word: failed.
If you are reading this guide, you have probably just been through this. We want to say, with complete sincerity: we are sorry. A failed IVF cycle is one of the most painful experiences a person can go through — not just physically, but emotionally, financially, and relationally. But we also want you to know this: a failed IVF cycle is not a verdict. It is a data point — one that, when properly analysed and understood, provides crucial information that makes the next attempt more intelligent, more targeted, and more likely to succeed.
What You Will Find in This Guide
This guide covers all 50 of the most searched and most asked questions by patients in India after a failed IVF cycle — why it failed, what tests to do, what to change, when to try again, the financial reality, whether to change clinics, lifestyle optimisation, donor eggs and other paths, recurrent implantation failure (RIF), and the emotional journey. Read it in full or jump to the section most relevant to you now.
The 'AA' designation in the Gardner blastocyst grading system refers to morphology — what the embryo looks like under a microscope. What it cannot assess is the chromosomal content of the embryo. An embryo can be visually perfect — beautifully expanded, Grade A in both parameters — and carry a trisomy 16, a monosomy 7, or any other chromosomal error that will make implantation biologically impossible regardless of the surrounding environment.
The clinical implication: a good-looking embryo that failed to implant was almost certainly chromosomally abnormal. The most informative next step is PGT-A in your next cycle — so that embryos going forward have confirmed chromosomal normalcy before transfer.
| Age Group | Fertilisation Rate | Blastocyst Rate | Implantation Rate | Clinical Pregnancy Rate | Live Birth Rate per Cycle |
|---|---|---|---|---|---|
| Under 30 | 85–90% | 55–65% | 45–55% | 50–60% | 45–55% |
| 30–34 | 82–88% | 50–60% | 40–50% | 42–52% | 38–48% |
| 35–37 | 78–85% | 42–55% | 32–42% | 35–45% | 28–40% |
| 38–40 | 72–80% | 35–47% | 22–35% | 25–35% | 18–30% |
| 40–42 | 62–75% | 25–38% | 15–24% | 16–26% | 10–20% |
| 43+ | 50–65% | 15–28% | 8–15% | 8–14% | 4–10% |
The Statistics Context
If you are 34 years old and your clinic achieves industry-standard results, there is a 50–60% chance your cycle will NOT result in a live birth. This is the reality — not a failure of your clinic, and not a failure of your body. It is the inherent probability of the process. Understanding this context does not make the pain of failure smaller. But it does reframe failure as a statistically expected event rather than an exceptional catastrophe.
If you have had one or two failed cycles with apparently good embryos: assume the embryo's chromosomal quality is the most likely issue and address that first — through PGT-A in the next cycle. Uterine investigation becomes necessary when the embryo quality is known to be good and transfer continues to fail. Three specific uterine factors are worth understanding:
1. The Window of Implantation — Timing Is Everything
In approximately 25% of women with recurrent implantation failure, the implantation window is displaced — it opens earlier or later than expected. This means that transfers done on the 'standard' day consistently miss the optimal moment. The ERA (Endometrial Receptivity Analysis) test detects this displacement and allows the doctor to correct the transfer timing.
2. Chronic Endometritis — The Silent Infection
Chronic endometritis (CE) is a low-grade, chronic inflammation of the uterine lining caused by bacterial colonisation. Critically, CE is asymptomatic — no pain, no abnormal discharge, no irregular periods, nothing on standard ultrasound. Yet it is present in approximately 15% of all infertile women and approximately 30% of women with recurrent implantation failure. The good news: CE is completely treatable with a targeted 2–3 week course of antibiotics.
3. Suboptimal Progesterone Levels
If blood progesterone on the day of transfer is below a threshold (approximately 10–15 ng/ml), implantation failure risk increases significantly. This is an underappreciated and easily correctable cause of failed transfer. At Shree IVF Clinic, we routinely check progesterone levels on the transfer day and adjust supplementation if levels are suboptimal.
Exercise after transfer: Light walking is fine and does not affect implantation. The embryo must actively invade the endometrium through a complex biochemical process — it is not mechanically placed on a shelf.
Food and diet: Eating a non-organic vegetable, drinking one cup of coffee, or having a small piece of cake after transfer did not cause the failure. A food choice made after transfer cannot cause failure.
Stress: The anxiety of the two-week wait — inevitable and universal — does not cause the cycle to fail. Chronic severe stress over months can affect the hormonal environment, but acute two-week wait anxiety does not cause implantation failure.
The One Thing That Can Genuinely Affect Outcomes
The one thing that can genuinely affect outcomes during a cycle is medication adherence — taking progesterone pessaries at the correct time, not missing doses, storing medications correctly. This is worth reviewing if you have any doubt. Everything else on the list of 'what I might have done wrong' is almost certainly not relevant.
When a doctor says your IVF failure is 'unexplained,' it usually means your embryos looked morphologically normal, your uterine lining appeared adequate on ultrasound, and standard hormonal tests were within normal range. What it does NOT mean is that deeper investigation was performed. The following are not part of a standard IVF workup and are NOT typically done unless specifically requested:
- PGT-A — genetic testing of the embryo (reveals chromosomal abnormalities invisible to visual grading)
- SDF (Sperm DNA Fragmentation) — reveals DNA damage in sperm invisible to standard semen analysis
- ERA (Endometrial Receptivity Analysis) — detects displaced implantation window
- EMMA + ALICE — detects silent uterine infection and microbiome imbalance
- Immunological testing — detects NK cells, cytokines, and thrombophilia
At Shree IVF Clinic, no patient leaves a failed cycle review without a systematic plan to investigate every possible underlying cause. 'Unexplained' is never accepted as a conclusion — it is a prompt for deeper investigation.
| Investigation | After 1st Failure | After 2nd Failure | After 3rd+ Failure | What It Detects |
|---|---|---|---|---|
| Embryology report review | Essential | Essential | Essential | Egg quality, fertilisation, development issues |
| Progesterone blood level on transfer day | Essential | Essential | Essential | Inadequate luteal support (<10–12 ng/ml) |
| Thyroid function (TSH, Free T4) | Recommended | Essential | Essential | Thyroid-related implantation failure |
| Vitamin D (25-OH) | Recommended | Essential | Essential | Deficiency — very common in Indian women |
| Sperm DNA Fragmentation (SDF) | Consider if embryos poor | Essential | Essential | Male-factor embryo quality (missed by standard SA) |
| ERA (Endometrial Receptivity Analysis) | Optional | Strongly recommended | Essential | Displaced implantation window (25% of RIF patients) |
| EMMA + ALICE | Optional | Strongly recommended | Essential | Uterine microbiome + chronic endometritis |
| Hysteroscopy / 3D Ultrasound | If not done before | Essential | Essential | Polyps, fibroids, septum, adhesions |
| Thrombophilia panel | Optional | Recommended | Essential | Blood clotting issues impairing implantation |
| Karyotype (both partners) | If embryo quality poor | Recommended | Essential | Chromosomal translocations |
| PGT-A (next cycle embryos) | Optional for >38 | Strongly recommended | Essential | Chromosomal abnormality in embryos |
| Immunology (uNK cells, cytokines) | Not routine | Consider | Essential for recurrent | Immune-mediated implantation failure |
When a sperm with high DNA fragmentation fertilises an egg, the embryo inherits the damaged DNA. The egg can repair some of this damage in the first 24–48 hours — but if the damage is extensive (SDF above 30%), the repair mechanisms are overwhelmed. The embryo may fertilise normally on Day 1, divide acceptably on Days 2–3, but then arrest before or during blastocyst formation.
- SDF above 15–25%: associated with reduced blastocyst development rates, increased embryo fragmentation, and elevated miscarriage risk
- SDF above 30–40%: associated with significantly poor embryo development, repeated IVF failure, and recurrent early pregnancy loss
- A normal semen analysis does NOT exclude high SDF
If SDF is elevated, there are effective interventions: antioxidant therapy (Vitamin C, E, zinc, selenium, CoQ10, Lycopene for 3–4 months), lifestyle changes (stop smoking, reduce alcohol, avoid heat), varicocele surgery (if varicocele is present), and testicular sperm retrieval (TESA) — testicular sperm often has significantly lower SDF than ejaculated sperm.
In a standard medicated FET protocol, the window is assumed to occur on a fixed day (typically 5 days of progesterone for a Day 5 blastocyst transfer). But in approximately 25–30% of women with recurrent implantation failure, this window is displaced:
- Pre-receptive: The window opens later than expected (transfer day should be moved 12–24 hours later)
- Post-receptive: The window has already closed (transfer day should be moved earlier)
If you are always transferring on the 'standard' day and your window is consistently displaced, every transfer — regardless of embryo quality or protocol — will miss the window. The ERA test is performed by taking a small endometrial biopsy on the planned 'standard' transfer day, before any actual transfer cycle. The result tells you either 'receptive' (window is standard) or 'displaced' (window is early or late by a specific number of hours).
EMMA — What Lives in Your Uterus Matters: The uterus was once thought to be a sterile environment. We now know it has its own microbiome. When the uterine microbiome is abnormal — dominated by non-Lactobacillus bacteria (Gardnerella, Streptococcus, Enterococcus, Staphylococcus) — implantation rates are significantly reduced. Treatment with targeted probiotics and/or antibiotics can restore a healthy Lactobacillus-dominant environment before the next transfer.
ALICE — Detecting Chronic Endometritis: ALICE specifically tests for the pathogens associated with chronic endometritis (CE) using DNA analysis — more sensitive than traditional histological diagnosis. When CE-causing pathogens are identified, a specific antibiotic course is prescribed. Treatment of CE has been shown in multiple studies to significantly improve implantation rates in women with recurrent implantation failure.
The argument for PGT-A after failed IVF:
- PGT-A identifies which embryos are chromosomally normal (euploid) before transfer, allowing you to transfer only those with the highest probability of success
- In women over 38 with previous failed cycles, PGT-A significantly reduces the per-transfer miscarriage rate and improves live birth rates per transfer
- PGT-A can also provide diagnostic information — if all embryos across a cycle are aneuploid, this tells you the primary problem is chromosomal (most likely egg quality) rather than uterine
The consideration against PGT-A for some patients: In young women under 35 with first-cycle failure, PGT-A may not add enough value to justify the additional cost (~₹50,000–₹80,000 for the testing). PGT-A requires all embryos to be frozen. There is a small risk (1–2%) of embryo damage from the biopsy procedure in inexperienced hands.
Discuss PGT-A with your doctor in the context of your age, previous failures, and what your embryology report showed. Dr. Jay Mehta provides a clear recommendation on PGT-A based on your specific situation, including an honest cost-benefit analysis.
| Add-On Treatment | Evidence Level | Who Benefits | Recommendation |
|---|---|---|---|
| Growth Hormone | Good (meta-analyses) | Poor ovarian responders; DOR | Recommended for poor responders |
| Low-dose Aspirin | Moderate | Thin endometrium; thrombophilia; general IVF | Widely used; low risk; reasonable |
| LMWH (Heparin) | Good for thrombophilia | Confirmed thrombophilia (APS, FVL) | Only if thrombophilia proven |
| Corticosteroids | Limited | Elevated uNK cells; autoimmune suspicion | Optional; most useful for elevated uNK |
| Intralipid | Limited | Elevated uNK cells; recurrent RIF | Experimental; discuss with doctor |
| Progesterone blood level check + add-on | Strong | Low progesterone on transfer day | Should be routine; simple and effective |
| PRP intrauterine infusion | Emerging — limited RCTs | Thin endometrium; recurrent failure | Optional; growing evidence |
| ERA / pET | Good for RIF | Recurrent implantation failure | Strongly recommended for 2+ failed cycles |
| Time-lapse incubation | Good | All patients; especially recurrent failure | Recommended at quality clinics |
| TESA for high SDF | Good | SDF >30%; recurrent poor embryo development | Strongly recommended if SDF elevated |
Advantages of FET Over Fresh Transfer: Better endometrial environment (avoids supraphysiological estrogen); PGT-A compatibility (embryos must be frozen — results take 1–2 weeks); OHSS risk elimination (particularly for PCOS, high AMH patients); better synchronisation; and more time for endometrial optimisation.
When Fresh Transfer Is Still Reasonable: Fresh transfer remains reasonable when the patient is young with good prognosis, no OHSS risk, no indication for PGT-A, endometrial appearance is ideal on transfer day, and progesterone levels are confirmed adequate. At Shree IVF Clinic, the fresh versus freeze-all decision is made individually for each patient.
| Protocol Type | How It Works | Best For | Advantages | Disadvantages |
|---|---|---|---|---|
| Natural Cycle FET | Body's own hormones prepare endometrium | Women with regular ovulation; previous poor response to meds | Physiological; no daily injections; cheaper | Cycle may be cancelled if ovulation problems |
| Modified Natural + Trigger | Natural cycle + hCG trigger for precise ovulation timing | Regular ovulators wanting more control | Better timing precision; still uses own hormones | Requires more monitoring visits |
| Medicated (Artificial) Cycle | Estrogen + Progesterone prepare lining | Irregular cycles; anovulation; post-agonist | Full cycle control; no monitoring for ovulation | Exogenous hormones; may affect receptivity in some women |
| Progesterone Level-Guided | Medicated cycle with progesterone blood level check and timing adjustment | Previous failed medicated FETs | Personalised progesterone timing; evidence-backed | Requires more blood tests |
| ERA-Guided (pET) | Transfer timed to ERA test result | Recurrent implantation failure; displaced window | Completely personalised; strong evidence for RIF | Requires ERA biopsy cycle first; adds cost and time |
| IVF Cycle Number | Under 35 (Cumulative LBR) | 35–37 (Cumulative LBR) | 38–40 (Cumulative LBR) | 41–42 (Cumulative LBR) | 43+ (Cumulative LBR) |
|---|---|---|---|---|---|
| After Cycle 1 | 45–55% | 32–42% | 18–28% | 10–16% | 4–8% |
| After Cycle 2 | 65–75% | 50–62% | 30–42% | 18–26% | 7–13% |
| After Cycle 3 | 75–85% | 62–74% | 40–52% | 24–34% | 9–17% |
| After Cycle 4 | 82–90% | 70–80% | 48–60% | 30–40% | 12–20% |
| After Cycle 5 | 85–92% | 74–84% | 54–65% | 35–46% | 14–23% |
The practical guidance: after 1–2 failed cycles, investigate thoroughly and modify the protocol. After 3 failed cycles: comprehensive RIF workup. Donor egg discussion is appropriate if all embryos have been aneuploid on PGT-A or if AMH is very low and age is over 40. After 4+ failed cycles with own eggs: donor egg IVF should be seriously and openly discussed.
For Women Over 40 — Time Genuinely Matters
For women over 40, every cycle is precious, and cycles that do not produce euploid embryos are — from a medical efficiency standpoint — cycles that may not be worth repeating. A prolonged break without a specific medical reason is not advisable. The donor egg conversation should also begin if it has not already. The urgency is real — but it should empower action, not panic.
| Scenario | Procedure Cost | Medicines | Additional Tests | Approx. Total |
|---|---|---|---|---|
| Frozen Embryo Transfer (FET) | ₹20,000–40,000 | ₹10,000–25,000 | ERA/EMMA/ALICE: ₹25,000–45,000 | ₹55,000–1,10,000 |
| Second Fresh IVF Cycle (standard) | ₹80,000–1,10,000 | ₹60,000–90,000 | PGT-A: ₹50,000–80,000 | ₹1,90,000–2,80,000 |
| Cycle with Growth Hormone add-on | As above | + ₹25,000–50,000 for GH | As above | ₹2,40,000–3,30,000 |
| Donor Egg IVF | ₹80,000–1,20,000 | ₹20,000–40,000 | Donor screening: included | ₹3,00,000–5,00,000 |
| PGT-A add-on (to any fresh cycle) | Included in cycle | As above | ₹50,000–80,000 for testing | Add ₹70,000–1,00,000 to any cycle |
| Metric | Ask Your Clinic | Acceptable Benchmark | Red Flag |
|---|---|---|---|
| Fertilisation rate | How many eggs fertilised out of mature eggs? | 70–80% | Under 55% without explanation |
| Day 5 blastocyst rate | How many fertilised eggs reached Day 5 blastocyst? | 40–55% of fertilised eggs | Under 25% consistently |
| Post-thaw survival rate | What % of frozen embryos survive the thaw? | 85–92% | Under 75% |
| Transfer technique | Was transfer done under ultrasound guidance? | Always — non-negotiable | Transfer without ultrasound guidance |
| Progesterone monitoring | Was progesterone blood level checked on transfer day? | Should be standard practice | 'We don't routinely check' after failed FET |
| Post-failure workup | What specific tests are being ordered after this failure? | Individualised, systematic plan | 'Let's just try the same protocol again' |
If your doctor answers these questions with specific data, a clear rationale, and genuine engagement — that is a doctor worth trusting. If answers are vague, dismissive, or there is no specific plan — a second opinion is warranted. At Shree IVF Clinic, every post-failure review consultation with Dr. Jay Mehta is a thorough, data-driven conversation that results in a personalised modification plan for the next attempt.
| Supplement | For Whom | Dose | Duration | Evidence | Key Benefit |
|---|---|---|---|---|---|
| CoQ10 / Ubiquinol | All women, especially >35 or poor blastocyst history | 400–600mg/day | 3–4 months minimum | Good — RCTs and human studies | Mitochondrial energy; spindle function |
| DHEA | Women with DOR or poor ovarian response (NOT PCOS) | 25–50mg/day (micronised) | 3–6 months | Moderate | Improves follicular FSH sensitivity |
| Melatonin | Women with poor embryo quality or oxidative stress history | 3mg at night | 3 months | Moderate | Antioxidant in follicular fluid |
| Vitamin D3 | All women (most Indian women are deficient) | 2000–4000 IU/day | Ongoing once deficiency corrected | Good — strong observational data | Granulosa cell function; IVF success |
| Methylfolate | All fertility patients | 400–800 mcg/day | 3 months before and through pregnancy | Excellent | DNA methylation; neural tube prevention |
| Omega-3 (EPA+DHA) | All patients; especially endometriosis | 1–2g/day | 3 months | Moderate | Anti-inflammatory follicular environment |
| Myo-Inositol + D-Chiro (40:1) | PCOS patients; insulin resistant | 4g/day (2g BD) | 3 months | Good for PCOS (RCTs) | Improves follicular insulin sensitivity |
| Zinc + Selenium + Lycopene (Male) | Male partner if SDF elevated | Zinc 25mg + Selenium 100mcg + Lycopene 8mg/day | 3 months | Good for male fertility | Reduces sperm DNA fragmentation |
| Age of Recipient | Own Egg IVF (Live Birth per Transfer) | Donor Egg IVF (Live Birth per Transfer) | Miscarriage Rate: Own Eggs | Miscarriage Rate: Donor Eggs |
|---|---|---|---|---|
| Under 35 | 42–52% | 55–68% | 12–16% | 8–12% |
| 35–38 (first failure) | 28–38% | 55–68% | 16–22% | 8–12% |
| 38–40 (multiple failures) | 18–28% | 55–68% | 24–35% | 8–12% |
| 40–42 (multiple failures) | 10–18% | 55–68% | 35–50% | 8–12% |
| 43+ | 4–8% | 55–68% | 50–65% | 8–12% |
| POI / Premature Ovarian Failure | <5% | 55–68% | Very high | 8–12% |
The emotional journey to donor egg acceptance is real and deserves time and space. Research consistently shows that families formed through donor egg IVF report parent-child bonds, family cohesion, and child development outcomes that are indistinguishable from naturally conceived families. At Shree IVF Clinic, we never rush this conversation. All donor egg IVF in India is governed by the ART Act, 2021 — donors are anonymous, registered at accredited ART Banks, and aged 23–35.
| Investigation Category | Specific Tests | What It Detects | Action If Abnormal |
|---|---|---|---|
| Embryo genetics | PGT-A on future embryos | Aneuploid embryos being transferred unknowingly | Transfer only euploid embryos |
| Endometrial timing | ERA (Endometrial Receptivity Analysis) | Displaced implantation window (25% of RIF patients) | Personalised embryo transfer (pET) |
| Uterine microbiome | EMMA (Endometrial Microbiome) | Non-Lactobacillus dominant microbiome | Targeted probiotics + antibiotics |
| Uterine infection | ALICE (Infectious Chronic Endometritis) | CE-causing pathogens (CE present in 30% of RIF) | Targeted antibiotic course (14–21 days) |
| Uterine structure | Hysteroscopy + 3D ultrasound | Polyps, fibroids, septum, adhesions | Hysteroscopic removal/correction |
| Immune factors | uNK cell density (CD56 staining on biopsy) | Elevated uterine NK cells | Prednisolone; intralipid infusion; IVIG (selected cases) |
| Immune factors | ANA, anti-dsDNA, antiphospholipid antibodies | Autoimmune causes | Immunosuppression; anticoagulation |
| Thrombophilia | Factor V Leiden, MTHFR, Protein C/S, antithrombin III | Clotting disorders impairing implantation | LMWH anticoagulation from embryo transfer |
| Male factor | SDF (if not done) | High sperm DNA fragmentation | TESA; antioxidants; IMSI |
| Karyotype (both partners) | Chromosomal analysis | Balanced translocations | PGT-SR for future cycles |
| Luteal support | Progesterone level on transfer day | Subthreshold progesterone (<10–12 ng/ml) | Increase progesterone supplementation |
| Thyroid + TPO antibodies | TSH, Free T4, TPO antibodies | Thyroid dysfunction; Hashimoto's (even with normal TSH) | Optimise TSH to 0.5–2.5; consider LT4 even for borderline Hashimoto's |
| Metabolic | Fasting insulin, HbA1c, Vitamin D | Insulin resistance; Vitamin D deficiency | Metformin/myo-inositol; Vitamin D correction |
Book Your Post-Failure Review — Dr. Jay Mehta, Shree IVF Clinic
Whether this is your first failed cycle or your fourth, whether you are coming from across the street or from another city entirely — Dr. Jay Mehta reviews your complete history, identifies what has been missed, and builds you a plan that is actually different. Complete review of all previous IVF embryology and clinical data. Honest success rate assessment. Complete cost transparency. Remote support for out-of-city patients — all monitoring in your home city, travel to Mumbai only when needed.
The Emotional Reality of Failed IVF — Grieving, Coping, and Moving Forward
No guide to failed IVF is complete without an honest, extended section on the emotional dimension. Failed IVF is a unique form of grief — it is the loss of a hoped-for future, the loss of a pregnancy that was already emotionally 'real' from the moment of transfer, and the loss of control over one of the most fundamental human desires.
The Grief Is Real
If you feel devastated after a failed IVF cycle, you are not being 'dramatic' or 'oversensitive.' The specific grief of IVF failure has characteristics that make it particularly difficult: it is an ambiguous loss (grieving something that never fully existed); it is cyclical (each failed cycle re-opens the wound); it is isolating (most couples keep treatment secret); and in India, the social pressure to produce children adds a layer of shame, inadequacy, and social judgment that compounds the personal grief.
Protecting Your Relationship
Failed IVF puts relationships under enormous strain. The physical burden falls predominantly on the woman. The emotional experience, while shared, is often asynchronous — partners process grief differently and at different speeds. Evidence-based strategies for protecting your relationship: designate 'IVF-free' time; communicate about grief differences; maintain physical intimacy that is not about conception; make decisions together; and consider couples counselling (brief, 4–6 sessions can significantly improve communication).
The Right to Stop
You have the right to stop. At any point, for any reason — financial, emotional, physical, or simply because you have decided that this is not the path you want to continue. Stopping IVF does not mean giving up on parenthood — it may mean choosing a different path (donor eggs, adoption, foster care, child-free living). All of these are valid. All of these can be fulfilling. At Shree IVF Clinic, psychological support and fertility-specific counselling referrals are available.
When Professional Support Is Needed
Seek professional psychological support when: you are experiencing persistent sadness or hopelessness for more than 2 weeks continuously; sleep disturbance, appetite changes, or concentration problems are affecting daily functioning; anxiety about treatment is preventing you from continuing necessary procedures; or relationship conflict related to IVF is escalating. Fertility-specific counselling is available through Shree IVF Clinic referrals. iCall India: 9152987821.
Frequently Asked Questions — Failed IVF in India
⚠️ Warning Signs After a Failed IVF Cycle — When to Act Immediately
PHYSICAL WARNING SIGNS (Call immediately):
- Severe abdominal pain or bloating that is worsening — possible delayed OHSS
- Fever above 38°C in the 2 weeks following egg retrieval — possible infection
- Heavy vaginal bleeding (soaking more than 2 pads per hour)
- Shortness of breath, chest pain, or leg swelling — possible blood clot (DVT)
- Signs of ectopic pregnancy: one-sided sharp pelvic pain, shoulder tip pain, vaginal bleeding despite positive beta-hCG
EMOTIONAL WARNING SIGNS (Seek support):
- Thoughts of self-harm or feeling life is not worth living — please call iCall India: 9152987821
- Complete inability to function (get out of bed, eat, go to work) for more than 7 days
- Panic attacks that are increasing in frequency
RED FLAGS IN MEDICAL MANAGEMENT (Get a second opinion):
- Your doctor has given no explanation for your repeated failures beyond 'it didn't work'
- You have had 3+ failed transfers and SDF, ERA, and PGT-A have never been discussed
- You are being pressured to do another cycle immediately without any protocol change
- You have never been offered a formal post-failure review consultation
📞 +91-9920914115 | Toll-Free: 18002684000 | 8 AM – 8 PM, Monday to Saturday
iCall India (Mental Health): 9152987821 | NIMHANS (Bengaluru): 080-46110007
Online Consultations Available — India & International. Out-of-city patients: most monitoring can be done near your home.
Glossary — Key Terms Explained in Plain Language
- ALICE (Analysis of Infectious Chronic Endometritis)
- A DNA-based test on endometrial biopsy that detects pathogens causing chronic endometritis — a silent infection associated with recurrent implantation failure. Present in approximately 30% of RIF patients. Completely treatable with targeted antibiotics when identified.
- AMH (Anti-Mullerian Hormone)
- Blood test measuring ovarian reserve — how many eggs remain. Does not measure egg quality directly. Low AMH in a young woman indicates low quantity but not necessarily poor quality.
- Aneuploidy
- Having the wrong number of chromosomes. The leading cause of implantation failure and early miscarriage. Caused primarily by errors in the egg during its maturation. Rates increase significantly with maternal age.
- Biochemical / Chemical Pregnancy
- A pregnancy confirmed only by a rising beta-hCG blood test, without a visible gestational sac on ultrasound. A very early implantation that fails before the sac forms. In 60–70% of cases, caused by chromosomal abnormality in the embryo.
- Chronic Endometritis (CE)
- A low-grade, asymptomatic bacterial infection of the uterine lining. Present in approximately 30% of recurrent implantation failure patients. Has no symptoms — not detectable on standard ultrasound. Treatable with antibiotics. Detected by ALICE test or CD138 staining on endometrial biopsy.
- Displaced Implantation Window
- When the endometrium's receptive period occurs earlier or later than the standard day — causing transfers done on the 'usual' day to consistently miss the optimal moment. Detected by ERA test. Present in approximately 25% of recurrent implantation failure patients.
- ERA (Endometrial Receptivity Analysis)
- A gene expression test on an endometrial biopsy that determines whether the endometrium is 'receptive' at the planned transfer time. Used to personalise transfer timing. If the window is displaced, the ERA result guides a 'personalised embryo transfer' (pET) timed to the individual patient's window.
- Euploid
- An embryo with the correct number of chromosomes (46). Confirmed by PGT-A. Euploid embryos have significantly higher implantation rates and dramatically lower miscarriage rates than untested or aneuploid embryos.
- EMMA (Endometrial Microbiome Metagenomic Analysis)
- A DNA-based test on endometrial biopsy that analyses the bacterial microbiome of the uterus. A Lactobacillus-dominant microbiome is associated with significantly better IVF outcomes. Non-Lactobacillus-dominant microbiomes are associated with a 3–4 fold reduction in implantation rates. Can be performed on the same biopsy sample as ERA and ALICE.
- FET (Frozen Embryo Transfer)
- Transfer of a previously cryopreserved (frozen) embryo in a subsequent cycle, after appropriate endometrial preparation. Typically one-third to one-quarter the cost of a fresh IVF cycle. Allows time for ERA, EMMA/ALICE, and other investigations.
- Gardner Grading System
- The most widely used blastocyst grading system — grades expansion (1–6), inner cell mass (A–C), and trophectoderm (A–C). A 5AA is the highest grade. Grades morphology only — cannot detect chromosomal abnormality. A Grade AA embryo can be chromosomally abnormal and fail to implant.
- IMSI (Intracytoplasmic Morphologically Selected Sperm Injection)
- ICSI at ultra-high magnification (6,000×) to select the best sperm for injection. Particularly valuable when SDF is elevated or there is a history of repeated embryo arrest or poor embryo development. Not universally superior to standard ICSI.
- LMWH (Low Molecular Weight Heparin)
- An anticoagulant (blood thinner) used in IVF for women with thrombophilia to prevent clotting-mediated implantation failure. Indicated only when thrombophilia is proven — not for routine IVF use.
- Personalised Embryo Transfer (pET)
- An embryo transfer timed according to the patient's individual ERA result, rather than the standard protocol day. Particularly effective for patients with a displaced implantation window, accounting for approximately 25% of RIF patients.
- PGT-A (Preimplantation Genetic Testing for Aneuploidy)
- Genetic testing of Day 5 blastocysts before transfer to identify chromosomally normal (euploid) embryos. Requires embryo biopsy and a freeze-all cycle. Particularly recommended for women over 38 and those with multiple failed cycles.
- RIF (Recurrent Implantation Failure)
- Failure of implantation after 3 or more transfers of good-quality embryos (or 2 euploid embryo transfers). Requires comprehensive investigation. A specific, treatable cause is found in approximately 60–70% of cases when systematically investigated.
- SDF (Sperm DNA Fragmentation)
- Damage to the DNA within sperm cells. NOT detected by standard semen analysis. Associated with poor embryo quality, embryo arrest, and recurrent miscarriage. A man can have entirely normal semen parameters and still have 40% DNA-damaged sperm. Testicular sperm (TESA) typically has significantly lower SDF than ejaculated sperm.
- TESA (Testicular Sperm Aspiration)
- Surgical retrieval of sperm directly from the testis. Testicular sperm has significantly lower DNA fragmentation than ejaculated sperm — making it the preferred source for ICSI when SDF is elevated. Used instead of ejaculated sperm in couples with high SDF and poor embryo development history.
- Thrombophilia
- A tendency toward abnormal blood clotting. Associated with recurrent implantation failure and pregnancy loss. Detected by a thrombophilia panel blood test. Includes antiphospholipid syndrome (APS), Factor V Leiden mutation, MTHFR gene mutations, and deficiencies in proteins C and S.
- TPO Antibodies (Thyroid Peroxidase Antibodies)
- Markers of Hashimoto's thyroiditis (autoimmune thyroid disease). Even with normal TSH, elevated TPO antibodies are associated with increased miscarriage risk and implantation failure. Part of the comprehensive RIF investigation protocol.
- Two-Week Wait (2WW)
- The 10–14 day period between embryo transfer and the beta-hCG blood test. Widely regarded as the most psychologically difficult phase of IVF. Acute anxiety during this period almost certainly does not cause implantation failure.
- uNK Cells (Uterine Natural Killer Cells)
- Immune cells present in the uterine lining. When elevated, they may contribute to implantation failure by creating a hostile immune environment for the embryo. Assessed by endometrial biopsy with CD56 staining. Managed with prednisolone or intralipid infusion in selected cases.
© 2025 Shree IVF Clinic. All Rights Reserved.
Dr. Jay Mehta
MBBS, DNB—Obstetrics & Gynecology
IVF & Endometriosis Specialist, Laparoscopic Surgeon (Obs & Gyn)
4.9
Verified & Most Trusted One
Dr. Jay Mehta is a highly renowned IVF specialist and fertility-preserving surgeon based in Mumbai, India. As the director of the Shree IVF and Endometriosis Clinic, Mumbai, he is recognized as one of India's leading laparoscopic gynecologists for the advanced treatment of complex conditions such as endometriosis and adenomyosis.
Dr. Mehta's expertise extends deeply into reproductive medicine; he is a well-known IVF specialist and among the few practitioners in the country with specialized knowledge in embryology, andrology, reproductive immunology, and Mullerian anomalies. Dr. Mehta conducts operations and consultations across India's major cities, including Pune, Chennai, Hyderabad, Bangalore, Ahmedabad, Agra, and Delhi. To book an appointment, call: 1800-268-4000
